iPSCs in gene therapy: Potent Solutions

Published on November 17, 2022

It’s no secret that gene therapy holds enormous potential in the field of medicine – and the promise of such potential has been the catalyst for innovation, exploration and many successes in the development of gene therapies. 

Continue reading on website
Other news

Next Generation Conjugates Summit

November 17, 2022
Abzena attended the Next Generation Conjugates Summit from 21st-23rd February 2023!The 2nd Next-Generation Conjugate Summit was your only platform dedicated to showcasing out-of-the-box technologies and approaches to design conjugates with novel modes of action.Below see Thomas Smith, from Novartis Institutes for BioMedical Research (NIBR) talk about ‘Extracellular Targeted Protein Degradation: An

Festival of Biologics USA

November 18, 2022
Abzena will be attending the Festvial of Biologics USA from 20th-22nd March 2023!The Festival of Biologics brings together pharma & biotech, academics and research institutes, together with their partners across the value chain. Across antibodies, immunotherapy and biosimilars our participants share research, create new partnerships, and tackle the clinical trials, manufacturing and commercial cha